Pages that link to "Q39541471"
Jump to navigation
Jump to search
The following pages link to José R. Fernández (Q39541471):
Displaying 50 items.
- Juan Viaño (Q20536054) (← links)
- Administration time-dependent effects of aspirin on blood pressure in untreated hypertensive patients (Q28195857) (← links)
- Comparison of parameters from rhythmometric models with multiple components on hybrid data (Q30954476) (← links)
- Influence of weather in the incidence of acute myocardial infarction in Galicia (Spain) (Q33462434) (← links)
- Comparison of the efficacy of morning versus evening administration of telmisartan in essential hypertension. (Q34652165) (← links)
- Influence of time of day of blood pressure-lowering treatment on cardiovascular risk in hypertensive patients with type 2 diabetes. (Q35043269) (← links)
- Circadian rhythms in blood pressure regulation and optimization of hypertension treatment with ACE inhibitor and ARB medications. (Q37798715) (← links)
- Chronotherapeutics of conventional blood pressure-lowering medications: simple, low-cost means of improving management and treatment outcomes of hypertensive-related disorders. (Q38177166) (← links)
- Sleep-time ambulatory blood pressure as a novel therapeutic target for cardiovascular risk reduction (Q38185598) (← links)
- Around-the-clock ambulatory blood pressure monitoring is required to properly diagnose resistant hypertension and assess associated vascular risk (Q38208966) (← links)
- Blunted sleep-time relative blood pressure decline increases cardiovascular risk independent of blood pressure level--the "normotensive non-dipper" paradox (Q39541406) (← links)
- Bedtime ingestion of hypertension medications reduces the risk of new-onset type 2 diabetes: a randomised controlled trial (Q41328936) (← links)
- Effects of time of antihypertensive treatment on ambulatory blood pressure and clinical characteristics of subjects with resistant hypertension (Q43203701) (← links)
- [2013 Ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals (summary). Joint recommendations from the In (Q43580643) (← links)
- Decreasing sleep-time blood pressure determined by ambulatory monitoring reduces cardiovascular risk (Q43759322) (← links)
- Morning surge, dipping, and sleep-time blood pressure as prognostic markers of cardiovascular risk (Q44270774) (← links)
- Treatment-time regimen of hypertension medications significantly affects ambulatory blood pressure and clinical characteristics of patients with resistant hypertension (Q44373377) (← links)
- Administration time-dependent effects of valsartan on ambulatory blood pressure in hypertensive subjects (Q44521145) (← links)
- Ambulatory blood pressure monitoring: importance of sampling rate and duration--48 versus 24 hours--on the accurate assessment of cardiovascular risk (Q44927482) (← links)
- Administration-time-dependent effects of doxazosin GITS on ambulatory blood pressure of hypertensive subjects (Q45033023) (← links)
- Sleep-time blood pressure as a therapeutic target for cardiovascular risk reduction in type 2 diabetes (Q45116862) (← links)
- Influence of circadian time of hypertension treatment on cardiovascular risk: results of the MAPEC study (Q45204771) (← links)
- Prevalence and clinical characteristics of isolated-office and true resistant hypertension determined by ambulatory blood pressure monitoring (Q45238291) (← links)
- Sleep-time blood pressure: prognostic value and relevance as a therapeutic target for cardiovascular risk reduction (Q45394467) (← links)
- Response to Comment on: Hermida et al. Influence of Time of Day of Blood Pressure–Lowering Treatment on Cardiovascular Risk in Hypertensive Patients With Type 2 Diabetes. Diabetes Care 2011;34:1270–1276. (Q45905284) (← links)
- Reduction of morning blood pressure surge after treatment with nifedipine GITS at bedtime, but not upon awakening, in essential hypertension. (Q45960148) (← links)
- Comparison of ambulatory blood pressure parameters of hypertensive patients with and without chronic kidney disease. (Q46016911) (← links)
- Ambulatory blood pressure control with bedtime aspirin administration in subjects with prehypertension. (Q46029457) (← links)
- Administration-time-dependent effects of olmesartan on the ambulatory blood pressure of essential hypertension patients (Q46163937) (← links)
- Association of metabolic syndrome and blood pressure nondipping profile in untreated hypertension (Q46170525) (← links)
- Comparison of the effects on ambulatory blood pressure of awakening versus bedtime administration of torasemide in essential hypertension (Q46249688) (← links)
- Abnormalities in chronic kidney disease of ambulatory blood pressure 24 h patterning and normalization by bedtime hypertension chronotherapy (Q46364064) (← links)
- Chronotherapy with nifedipine GITS in hypertensive patients: improved efficacy and safety with bedtime dosing (Q46502661) (← links)
- Administration time-dependent effects of valsartan on ambulatory blood pressure in elderly hypertensive subjects (Q46691102) (← links)
- Cardiovascular risk of essential hypertension: influence of class, number, and treatment-time regimen of hypertension medications (Q46880145) (← links)
- Chronotherapy with conventional blood pressure medications improves management of hypertension and reduces cardiovascular and stroke risks (Q47910182) (← links)
- Elevated asleep BP as predictor of type 2 diabetes and therapeutic target for prevention (Q47911570) (← links)
- Sleep-time BP: prognostic marker of type 2 diabetes and therapeutic target for prevention (Q47934068) (← links)
- Role of time-of-day of hypertension treatment on the J-shaped relationship between blood pressure and cardiovascular risk (Q48210056) (← links)
- Ambulatory blood pressure thresholds for diagnosis of hypertension in patients with and without type 2 diabetes based on cardiovascular outcomes (Q48210123) (← links)
- Effects of time-of-day of hypertension treatment on ambulatory blood pressure and clinical characteristics of patients with type 2 diabetes (Q48210138) (← links)
- Clinical application of a novel automatic algorithm for actigraphy-based activity and rest period identification to accurately determine awake and asleep ambulatory blood pressure parameters and cardiovascular risk (Q48213872) (← links)
- Influence of age and hypertension treatment-time on ambulatory blood pressure in hypertensive patients (Q48217228) (← links)
- Cardiovascular risk of resistant hypertension: dependence on treatment-time regimen of blood pressure-lowering medications (Q48217241) (← links)
- Sleep-time blood pressure and the prognostic value of isolated-office and masked hypertension (Q48273841) (← links)
- Chronotherapy with valsartan/hydrochlorothiazide combination in essential hypertension: improved sleep-time blood pressure control with bedtime dosing (Q48289407) (← links)
- Relationship between metabolic syndrome, circadian treatment time, and blood pressure non-dipping profile in essential hypertension (Q48291139) (← links)
- Modeling the circadian variability of ambulatorily monitored blood pressure by multiple-component analysis (Q48661397) (← links)
- Circadian rhythm of double (rate-pressure) product in healthy normotensive young subjects (Q48686516) (← links)
- The population RDH index: a novel vector index and graphical method for statistical assessment of antihypertensive treatment reduction, duration, and homogeneity (Q51201238) (← links)